FDA Adverse Event Injury Summary report: N

VASCURE FOR VASCULAR REPAIR

MDR report key: 9404964 · Received December 3, 2019

Report

Report Number
3005619880-2019-00013
Event Type
Injury
Date Received
December 3, 2019
Date of Event
October 30, 2019
Report Date
December 3, 2019
Manufacturer
AZIYO BIOLOGICS, INC.
Product Code
DXZ
UDI-DI
10859389005147
PMA / PMN Number
K140789
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

MANUFACTURING REVIEW OF THE DEVICE HISTORY RECORD FOR THE REPORTED LOT SHOWS THAT ALL UNITS WERE QUALITY RELEASED ON 06/11/2019 HAVING MET ALL INTERNAL QC ACCEPTANCE REQUIREMENTS. THERE WERE NO NON-CONFORMANCES ASSOCIATED WITH THE MANUFACTURING LOT DURING PRODUCTION AND FINAL PACKAGING. THE OEM SUPPLIER REVIEWED THE SUB-LOTS ASSOCIATED WITH THE REPORTED LOT AND CONFIRMED THAT "ALL DEVICES MET SPECIFICATION." THE INSTRUCTIONS FOR USE SUPPLIED WITH THE VASCULAR PRODUCT (ART-20708A) WAS REVIEWED. UNDER THE SECTION 'POTENTIAL COMPLICATIONS', IT STATES IN PART: "THE FOLLOWING COMPLICATIONS ARE POSSIBLE. IF ANY OF THESE CONDITIONS OCCUR, THE VASCURE SHOULD BE REMOVED. INFECTION". THE EXACT CAUSE OF THE REPORTED EVENT CANNOT BE CONCLUSIVELY DETERMINED BUT IS A KNOWN POTENTIAL COMPLICATION.

Description of Event or Problem · 1

IT WAS REPORTED THAT A CAROTID ENDARTERECTOMY WAS PERFORMED ON (B)(6) 2019. THE VASCURE WAS SOAKED FOR LESS THAN ONE MINUTE IN SALINE AND WAS SEWN TO PATIENT TISSUE. THE PATIENT REQUIRED SURGICAL INTERVENTION AND WAS RE-OPERATED ON (B)(6) 2019 TO RESOLVE WHAT WAS DESCRIBED AS A "BLOW OUT OF THE AZIYO CAROTID PATCH". THE PROBABLE CAUSE OF THE EVENT PER THE PHYSICIAN WAS INFECTION; THE PATIENT TESTED POSITIVE FOR GRAM NEGATIVE INFECTION (STAPH SCHLEIFERI AND STAPH HOMINIS). THE VASCURE PRODUCT WAS EXPLANTED AND REPLACED WITH A BOVINE PATCH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1198289 VASCURE FOR VASCULAR REPAIR VASCURE FOR VASCULAR REPAIR DXZ AZIYO BIOLOGICS, INC. CMCV-014-609 M19F1240 10859389005147

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention